The Cyprus Stock Exchange (CSE) council on Friday announced the admission to trading of 4,167 additional shares of iDNA Genomics Public Ltd on the Emerging Companies Market.

According to the announcement, the shares were issued following the conversion of 100 convertible bonds into shares, in accordance with Article 58 of the CSE Law.

The newly admitted shares will be incorporated into the company’s existing listed share capital, increasing the total number of shares to 2,764,500 shares.

The exchange also stated that, as a result of the conversion, the number of convertible bonds traded on the CSE under the code IDNAB28 will decrease to 700 bonds.

Moreover, trading of the new shares is set to commence on March 30, 2026, when the updated quantities of the listed securities will also take effect.